Ultra Pure & DNA-Free Molecular Portfolio: Product Technical Guide

High-sensitivity molecular workflows leave little room for contamination. From qPCR and ddPCR to viral RNA detection and cfDNA liquid biopsy, trace DNA, nickase, DNase, or RNase can distort signal, compromise controls, and slow assay development. MilliporeSigma’s Ultra pure & DNA-free molecular portfolio is positioned to reduce that risk with contamination-tested PCR reagents, additives, and magnetic particle-based isolation components manufactured under controlled conditions and supported by lot-specific Certificates of Analysis. Clear workflow examples show how these components work together, from viral RNA isolation and RT-qPCR to plasma cfDNA extraction and rare variant detection by qPCR or ddPCR.
Access the full datasheet to get a practical look at purity standards, workflow integration, and quality controls worth building around.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.